CARGO Therapeutics, Inc.
CIK 0001966494
Revenue (TTM)
—
Q2 Aug 2025
Net Income (TTM)
−$220.69M
−70.7% YoY
Q2 Aug 2025
EPS Diluted (TTM)
−$4.71
+77.5% YoY
Q2 Aug 2025
Gross Margin
—
Q2 Aug 2025
Operating Margin
—
Q2 Aug 2025
Net Margin
—
Q2 Aug 2025
Free Cash Flow (TTM)
−$144.19M
Q2 Aug 2025
Cash
$107.75M
Q2 Aug 2025
Total Debt
—
Q2 Aug 2025
Shares Outstanding
48.36M sh
Q2 Aug 2025
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.